\nWith over 1300 suppliers, AstraZeneca has a large and complex global partner network. However, legacy ways of working with its suppliers were undermining accountability and responsiveness during quality events.\n<\/p>\n
\nThe company decided to extend access to suppliers directly within the ³Ô¹Ï±¬ÁÏ Vault Platform to improve efficiency, flexibility, and compliance. Being able to collaborate directly with partners on documents, audits, and quality events has led to fewer bottlenecks and faster cycle times.\n<\/p>\n
\nAstraZeneca\u2019s partners carry out many product-related activities, including API and full manufacturing, testing, distribution, and logistics. Over time, relying on manual workflows and email communication with suppliers created several challenges:<\/p>\n
\nDriven initially by a requirement to collaborate externally on audit findings, AstraZeneca decided to leverage ³Ô¹Ï±¬ÁÏ Quality Cloud to embed partners into key quality processes.\n<\/p>\n
\nBy bringing partners directly into its systems, AstraZeneca has built trust and reduced friction when managing quality processes. It now uses ³Ô¹Ï±¬ÁÏ QMS and ³Ô¹Ï±¬ÁÏ QualityDocs to collaborate with its suppliers on:<\/p>\n
\nAstraZeneca can now grant partners time-limited access to complete specific tasks or activities. Allocating licenses in this way ensures data remains secure and partners have access to the information they need.\n<\/p>\n
\nBy working into the same system, both parties benefit from comprehensive, real-time audit trail visibility. Tasks are easier to monitor and accountability is clear even when specific individuals are unavailable. Ultimately, smoother partner collaboration prevents delays and accelerates overall cycle times.\n<\/p>\n